Phase Ib/IIa Study of an Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination with Carboplatin-Paclitaxel in Patients with Chemo-therapy Naïve Advanced Non Small Cell Lung Cancer

Abstracts/Posters/Presentations:

• Karen Kelly, Nasser Hanna, Arthur Rosenberg, Paul Bunn, Jr., and Michael N. Needle. A Multi-Centered Phase I/II Study of Cetuximab in Combination with Paclitaxel and Carboplatin in Untreated Patients with Stage IV Non-Small Cell Lung Cancer: A Hoosier Oncology Group Study LUN01-25. Poster presentation at the ASCO annual meeting May 31-June 3, 2003, Chicago, IL